Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by CANADA INTERNATIONAL PHARMACY ASSOCIATION
Lobbying Relationship
Bills mentioned
H.R.1480: Safe and Affordable Drugs from Canada Act of 2017
Sponsor: Chellie Pingree (D-Maine)
S.92: Safe and Affordable Drugs from Canada Act of 2017
Sponsor: John McCain (R-Ariz.)
S.469: Affordable and Safe Prescription Drug Importation Act
Sponsor: Bernard Sanders (ID-Vt.)
S.122: Safe and Affordable Drugs from Canada Act of 2015
Sponsor: John McCain (R-Ariz.)
H.R.2228: Safe and Affordable Drugs from Canada Act of 2015
Sponsor: Chellie Pingree (D-Maine)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Rob Placek | Legislative Correspondent - Sen. Mike Johanns (R-NE) |
| Paul Frazer | n/a |
| Geoff Gleason | n/a |
| Bryan Tackett | n/a |
| Walter Torres | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate